A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis

NCT03928704 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonradiographic Axial Spondyloarthritis

Interventions

DRUG: Bimekizumab
OTHER: Placebo

Sponsor

UCB Biopharma SRL